112 related articles for article (PubMed ID: 35535453)
1. A novel role for aspirin in enhancing the reprogramming function of miR-302/367 cluster and breast tumor suppression.
Rezania MA; Eghtedari A; Taha MF; Ardekani AM; Javeri A
J Cell Biochem; 2022 Jun; 123(6):1077-1090. PubMed ID: 35535453
[TBL] [Abstract][Full Text] [Related]
2. Vitamin C counteracts miR-302/367-induced reprogramming of human breast cancer cells and restores their invasive and proliferative capacity.
Ramezankhani B; Taha MF; Javeri A
J Cell Physiol; 2019 Mar; 234(3):2672-2682. PubMed ID: 30191953
[TBL] [Abstract][Full Text] [Related]
3. miR-16 enhances miR-302/367-induced reprogramming and tumor suppression in breast cancer cells.
Hoseinbeyki M; Taha MF; Javeri A
IUBMB Life; 2020 May; 72(5):1075-1086. PubMed ID: 32057163
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of microRNA-190 inhibits migration, invasion, epithelial-mesenchymal transition, and angiogenesis through suppression of protein kinase B-extracellular signal-regulated kinase signaling pathway via binding to stanniocalicin 2 in breast cancer.
Sun G; Liu M; Han H
J Cell Physiol; 2019 Aug; 234(10):17824-17838. PubMed ID: 30993707
[TBL] [Abstract][Full Text] [Related]
5. miR-524-5p of the primate-specific C19MC miRNA cluster targets TP53IPN1- and EMT-associated genes to regulate cellular reprogramming.
Nguyen PNN; Choo KB; Huang CJ; Sugii S; Cheong SK; Kamarul T
Stem Cell Res Ther; 2017 Sep; 8(1):214. PubMed ID: 28962647
[TBL] [Abstract][Full Text] [Related]
6. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q
Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanism of miR-153 inhibiting migration, invasion and epithelial-mesenchymal transition of breast cancer by regulating transforming growth factor beta (TGF-β) signaling pathway.
Wang J; Liang S; Duan X
J Cell Biochem; 2019 Jun; 120(6):9539-9546. PubMed ID: 30525231
[TBL] [Abstract][Full Text] [Related]
8. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
[TBL] [Abstract][Full Text] [Related]
9. Suppressive effect of exogenous miR-16 and miR-34a on tumorigenesis of breast cancer cells.
Haghi M; Taha MF; Javeri A
J Cell Biochem; 2019 Aug; 120(8):13342-13353. PubMed ID: 30916815
[TBL] [Abstract][Full Text] [Related]
10. Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells.
Han M; Liu M; Wang Y; Mo Z; Bi X; Liu Z; Fan Y; Chen X; Wu C
Mol Cell Biochem; 2012 Apr; 363(1-2):427-36. PubMed ID: 22187223
[TBL] [Abstract][Full Text] [Related]
11. Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial-mesenchymal transition.
Gao Y; Ma H; Gao C; Lv Y; Chen X; Xu R; Sun M; Liu X; Lu X; Pei X; Li P
J Transl Med; 2018 Feb; 16(1):38. PubMed ID: 29471858
[TBL] [Abstract][Full Text] [Related]
12. miR-145 suppresses epithelial-mesenchymal transition by targeting stem cells in Ewing sarcoma cells.
Guzel Tanoglu E; Ozturk S
Bratisl Lek Listy; 2021; 122(1):71-77. PubMed ID: 33393324
[TBL] [Abstract][Full Text] [Related]
13. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer.
Yan LX; Liu YH; Xiang JW; Wu QN; Xu LB; Luo XL; Zhu XL; Liu C; Xu FP; Luo DL; Mei P; Xu J; Zhang KP; Chen J
Int J Oncol; 2016 Feb; 48(2):471-84. PubMed ID: 26676464
[TBL] [Abstract][Full Text] [Related]
14. MiR-556-5p modulates migration, invasion, and epithelial-mesenchymal transition in breast cancer cells via targeting PTHrP.
Zhou R; Luo Z; Yin G; Yu L; Zhong H
J Mol Histol; 2022 Apr; 53(2):297-308. PubMed ID: 35000027
[TBL] [Abstract][Full Text] [Related]
15. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA HOXD-AS1 induces epithelial-mesenchymal transition in breast cancer by acting as a competing endogenous RNA of miR-421.
Li Y; Han X; Li Q; Wang C; Lou Z; Wang X
J Cell Biochem; 2019 Jun; 120(6):10633-10642. PubMed ID: 30730081
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the dual-faced effects of miR-141 with chitosan/miR-141 nanoplexes in breast cancer cells.
Kaban K; Salva E; Akbuga J
J Gene Med; 2019 Sep; 21(9):e3116. PubMed ID: 31389101
[TBL] [Abstract][Full Text] [Related]
18. miR-516a-3p inhibits breast cancer cell growth and EMT by blocking the Pygo2/Wnt signalling pathway.
Chi Y; Wang F; Zhang T; Xu H; Zhang Y; Shan Z; Wu S; Fan Q; Sun Y
J Cell Mol Med; 2019 Sep; 23(9):6295-6307. PubMed ID: 31273950
[TBL] [Abstract][Full Text] [Related]
19. Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTEN.
Han M; Liu M; Wang Y; Chen X; Xu J; Sun Y; Zhao L; Qu H; Fan Y; Wu C
PLoS One; 2012; 7(6):e39520. PubMed ID: 22761812
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-133a inhibits gastric cancer cells growth, migration, and epithelial-mesenchymal transition process by targeting presenilin 1.
Chen XB; Li W; Chu AX
J Cell Biochem; 2019 Jan; 120(1):470-480. PubMed ID: 30161272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
